Advertisement

Vitiligo pp 93-102 | Cite as

Halo Nevus, Leucotrichia and Mucosal Vitiligo

  • Anuradha Bishnoi
  • Davinder Parsad
Chapter

Abstract

Halo nevus is defined as a well-defined, symmetrical, round or oval, hypopigmented, or depigmented rim/halo around a central melanocytic nevus. The size of nevus and ring can vary from few millimeters to centimeters. In general, the diameter of halo correlates with the diameter of the nevus.

Leukotrichia refers to whitening of the hair associated with a depigmented vitiligo patch. Leukotrichia, poliosis, and canities are all characterized by whitening of the hair. Poliosis represents a circumscribed collection of white hair. It may or may not be associated with whitening of the underlying skin. Vitiligo may present with both leukotrichia and poliosis, and midline frontal hair poliosis identical to piebaldism can be seen in vitiligo. Canities refers to premature and generalized graying of hair in the scalp and beard.

The incidence of halo nevus and leukotrichia has been reported to be 4.4% and 12.3%, respectively.

In this chapter, we shall discuss about halo nevus, mucosal vitiligo and leucotrichia; and their significance in relation to vitiligo.

References

  1. 1.
    Rongioletti F, Cecchi F, Rebora A. Halo phenomenon in melanocytic nevi (Sutton’s nevi). Does the diameter matter? J Eur Acad Dermatol Venereol. 2011;25:1231–2.CrossRefGoogle Scholar
  2. 2.
    Pustisek N, Sikanic-Dugic N, Hirsl-Hecej V, Domljan ML. “Halo nevi” and UV radiation. Coll Antropol. 2010;34(Suppl 2):295–7.PubMedGoogle Scholar
  3. 3.
    Rubegni P, Nami N, Risulo M, Tataranno D, Fimiani M. Melanoma with halo. Clin Exp Dermatol. 2009;34:749–50.CrossRefGoogle Scholar
  4. 4.
    Polat Ekinci A, Kilic S, Baykal C. Pigment loss in patients with large congenital melanocytic nevi: various clinical presentations documented in a large series. Pediatr Dermatol. 2016;33:307.CrossRefGoogle Scholar
  5. 5.
    Wang K, Wang Z, Huang W. Resolution of vitiligo following excision of halo congenital melanocytic nevus: a rare case report. Dermatol Ther. 2016;29(3):145–7.Google Scholar
  6. 6.
    Brazzelli V, Larizza D, Martinetti M, Martinoli S, Calcaterra V, De Silvestri A, et al. Halo nevus, rather than vitiligo, is a typical dermatologic finding of turner’s syndrome: clinical, genetic, and immunogenetic study in 72 patients. J Am Acad Dermatol. 2004;51:354–8.CrossRefGoogle Scholar
  7. 7.
    Aouthmany M, Weinstein M, Zirwas MJ, Brodell RT. The natural history of halo nevi: a retrospective case series. J Am Acad Dermatol. 2012;67:582–6.CrossRefGoogle Scholar
  8. 8.
    Agarwal S, Ojha A, Gupta S. Profile of vitiligo in kumaun region of uttarakhand, India. Indian J Dermatol. 2014;59:209.CrossRefGoogle Scholar
  9. 9.
    Kalkanli N, Kalkanli S. Classification and comparative study of vitiligo in Southeast of Turkey with biochemical and immunological parameters. Clin Ter. 2013;164:397–402.PubMedGoogle Scholar
  10. 10.
    Khaitan BK, Kathuria S, Ramam M. A descriptive study to characterize segmental vitiligo. Indian J Dermatol Venereol Leprol. 2012;78:715–21.CrossRefGoogle Scholar
  11. 11.
    Lee DY, Kim CR, Park JH, Lee JH. The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment. Int J Dermatol. 2011;50:925–7.CrossRefGoogle Scholar
  12. 12.
    Ezzedine K, Diallo A, Leaute-Labreze C, Seneschal J, Prey S, Ballanger F, et al. Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo. Br J Dermatol. 2012a;166:539–44.CrossRefGoogle Scholar
  13. 13.
    Ezzedine K, Diallo A, Leaute-Labreze C, Seneschal J, Boniface K, Cario-Andre M, et al. Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo. Br J Dermatol. 2012b;167:490–5.CrossRefGoogle Scholar
  14. 14.
    Ezzedine K, Diallo A, Leaute-Labreze C, Seneschal J, Mossalayi D, AlGhamdi K, et al. Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern. Arch Dermatol. 2012c;148:497–502.CrossRefGoogle Scholar
  15. 15.
    Dave S, Thappa DM, Dsouza M. Clinical predictors of outcome in vitiligo. Indian J Dermatol Venereol Leprol. 2002;68:323–5.PubMedGoogle Scholar
  16. 16.
    Halder RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti SG, Kenney JA Jr. Childhood vitiligo. J Am Acad Dermatol. 1987;16:948–54.CrossRefGoogle Scholar
  17. 17.
    Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S, et al. High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol. 2014;171:786–98.CrossRefGoogle Scholar
  18. 18.
    Lee NR, Chung HC, Hong H, Lee JW, Ahn SK. Spontaneous involution of congenital melanocytic nevus with halo phenomenon. Am J Dermatopathol. 2015;37:e137–9.CrossRefGoogle Scholar
  19. 19.
    Sotiriou E, Apalla Z, Panagiotidou D, Ioannides D. Partial pigmentary regression of a congenital nevocytic naevus without halo phenomenon followed by generalized vitiligo. J Eur Acad Dermatol Venereol. 2009;23:600–1.CrossRefGoogle Scholar
  20. 20.
    Tobin DJ, Fenton DA, Kendall MD. Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata. J Invest Dermatol. 1990;94:803–7.CrossRefGoogle Scholar
  21. 21.
    Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol. 2001;36:29–54.CrossRefGoogle Scholar
  22. 22.
    Van Neste D, Tobin DJ. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron. 2004;35:193–200.CrossRefGoogle Scholar
  23. 23.
    Gan EY, Cario-Andre M, Pain C, Goussot JF, Taieb A, Seneschal J, et al. Follicular vitiligo: a report of 8 cases. J Am Acad Dermatol. 2016;74:1178–84.CrossRefGoogle Scholar
  24. 24.
    Mimouni D, David M, Feinmesser M, Coire CI, Hodak E. Vitiligo-like leucoderma during photochemotherapy for mycosis fungoides. Br J Dermatol. 2001;145:1008–14.CrossRefGoogle Scholar
  25. 25.
    Williams JS, Mufti GJ, du Vivier AW, Salisbury JR, Creamer D. Leucoderma and leucotrichia in association with chronic cutaneous graft-versus-host disease. Br J Dermatol. 2008;158:172–4.PubMedGoogle Scholar
  26. 26.
    Dhar S, Kanwar AJ, Ghosh S. Leucotrichia in nevus depigmentosus. Pediatr Dermatol. 1993;10:198–9.CrossRefGoogle Scholar
  27. 27.
    Kanwar AJ, Kaur S. Leucotrichia in discoid lupus erythematosus. Dermatology. 1992;184:232.CrossRefGoogle Scholar
  28. 28.
    Linn HW. Leucotrichia totalis from chloroquine. Med J Aust. 1959;46(2):360–1.PubMedGoogle Scholar
  29. 29.
    Lee DY, Jung KD, Park JH, Lee JH, Yang JM, Lee ES. Halo naevus is associated with leucotrichia: use of portable digital microscopy. J Eur Acad Dermatol Venereol. 2009;23:1095–6.CrossRefGoogle Scholar
  30. 30.
    Walker A, Mesinkovska NA, Boncher J, Tamburro J, Bergfeld WF. Colocalization of vitiligo and alopecia areata presenting as poliosis. J Cutan Pathol. 2015;42:150–4.CrossRefGoogle Scholar
  31. 31.
    Pandhi D, Khanna D. Premature graying of hair. Indian J Dermatol Venereol Leprol. 2013;79:641–53.CrossRefGoogle Scholar
  32. 32.
    Kocaman SA, Cetin M, Durakoglugil ME, Erdogan T, Canga A, Cicek Y, et al. The degree of premature hair graying as an independent risk marker for coronary artery disease: a predictor of biological age rather than chronological age. Anadolu Kardiyol Derg. 2012;12:457–63.PubMedGoogle Scholar
  33. 33.
    Chakrabarty S, Krishnappa PG, Gowda DG, Hiremath J. Factors Associated with Premature Hair Graying in a Young Indian Population. Int J Trichol. 2016;8:11–4.CrossRefGoogle Scholar
  34. 34.
    Shin H, Ryu HH, Yoon J, Jo S, Jang S, Choi M, et al. Association of premature hair graying with family history, smoking, and obesity: a cross-sectional study. J Am Acad Dermatol. 2015;72:321–7.CrossRefGoogle Scholar
  35. 35.
    Zeff RA, Freitag A, Grin CM, Grant-Kels JM. The immune response in halo nevi. J Am Acad Dermatol. 1997;37:620–4.CrossRefGoogle Scholar
  36. 36.
    Naveh HP, Rao UN, Butterfield LH. Melanoma-associated leukoderma - immunology in black and white? Pigment Cell Melanoma Res. 2013;26:796–804.CrossRefGoogle Scholar
  37. 37.
    Moretti S, Spallanzani A, Pinzi C, Prignano F, Fabbri P. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment? J Cutan Pathol. 2007;34:301–8.CrossRefGoogle Scholar
  38. 38.
    Cohen BE, Mu EW, Orlow SJ. Comparison of childhood vitiligo presenting with or without associated halo nevi. Pediatr Dermatol. 2016;33:44–8.CrossRefGoogle Scholar
  39. 39.
    Stierman SC, Tierney EP, Shwayder TA. Halo congenital nevocellular nevi associated with extralesional vitiligo: a case series with review of the literature. Pediatr Dermatol. 2009;26:414–24.CrossRefGoogle Scholar
  40. 40.
    van Geel N, Van Poucke L, Van de Maele B, Speeckaert R. Relevance of congenital melanocytic naevi in vitiligo. Br J Dermatol. 2015;172:1052–7.CrossRefGoogle Scholar
  41. 41.
    Concha-Garzon MJ, Hernandez-Martin A, Faura-Berruga C, Davila-Seijo P, Torrelo A. Spontaneous partial repigmentation of halo nevi around congenital melanocytic nevus and vitiligo in a 13-year-old boy. Indian J Dermatol Venereol Leprol. 2014;80:69–70.CrossRefGoogle Scholar
  42. 42.
    Ezzedine K, Le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res. 2014;27:134–9.CrossRefGoogle Scholar
  43. 43.
    van Geel N, Speeckaert R, Lambert J, Mollet I, De Keyser S, De Schepper S, et al. Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis. J Eur Acad Dermatol Venereol. 2012;26:755–61.CrossRefGoogle Scholar
  44. 44.
    van Geel N, Vandenhaute S, Speeckaert R, Brochez L, Mollet I, De Cooman L, et al. Prognostic value and clinical significance of halo naevi regarding vitiligo. Br J Dermatol. 2011;164:743–9.CrossRefGoogle Scholar
  45. 45.
    Patrizi A, Bentivogli M, Raone B, Dondi A, Tabanelli M, Neri I. Association of halo nevus/i and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol. 2013;27:e148–52.CrossRefGoogle Scholar
  46. 46.
    de Vijlder HC, Westerhof W, Schreuder GM, de Lange P, Claas FH. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res. 2004;17:270–4.CrossRefGoogle Scholar
  47. 47.
    Ding GZ, Zhao WE, Li X, Gong QL, Lu Y. A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin. Arch Dermatol Res. 2015;307:281–9.CrossRefGoogle Scholar
  48. 48.
    Schallreuter KU, Kothari S, Elwary S, Rokos H, Hasse S, Panske A. Molecular evidence that halo in Sutton’s naevus is not vitiligo. Arch Dermatol Res. 2003;295:223–8.CrossRefGoogle Scholar
  49. 49.
    Ezzedine K, Diallo A, Leaute-Labreze C, Mossalayi D, Gauthier Y, Bouchtnei S, et al. Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. Br J Dermatol. 2011;165:44–9.CrossRefGoogle Scholar
  50. 50.
    Nordlund JJ, Albert D, Forget B, Lerner AB. Halo nevi and the Vogt-Koyanagi-Harada syndrome. Manifestations of vitiligo. Arch Dermatol. 1980;116:690–2.CrossRefGoogle Scholar
  51. 51.
    van Geel N, Wallaeys E, Goh BK, De Mil M, Lambert J. Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus. Br J Dermatol. 2010;163:1186–93.CrossRefGoogle Scholar
  52. 52.
    Mulekar SV, Issa AA, Eisa AA. Treatment of halo nevus with a 308-nm excimer laser: a pilot study. J Cosmet Laser Ther. 2007;9:245–8.CrossRefGoogle Scholar
  53. 53.
    Kim MS, Cho EB, Park EJ, Kim KH, Kim KJ. Effect of excimer laser treatment on vitiliginous areas with leukotrichia after confirmation by dermoscopy. Int J Dermatol. 2016;55:886–92.CrossRefGoogle Scholar
  54. 54.
    Agrawal K, Agrawal A. Vitiligo: surgical repigmentation of leukotrichia. Dermatol Surg. 1995;21:711–5.PubMedGoogle Scholar
  55. 55.
    Thakur P, Sacchidanand S, Nataraj HV, Savitha AS. A study of hair follicular transplantation as a treatment option for vitiligo. J Cutan Aesthet Surg. 2015;8:211–7.CrossRefGoogle Scholar
  56. 56.
    Al Jasser MI, Ghwish B, Al Issa A, Mulekar SV. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation. Int J Dermatol. 2013;52:1383–6.CrossRefGoogle Scholar
  57. 57.
    Gan EY, van Geel N, Goh BK. Repigmentation of leucotrichia in vitiligo with noncultured cellular grafting. Br J Dermatol. 2012;166:196–9.CrossRefGoogle Scholar
  58. 58.
    Chatterjee M, Neema S, Vasudevan B, Dabbas D. Eyelash transplantation for the treatment of vitiligo associated eyelash leucotrichia. J Cutan Aesthet Surg. 2016;9:97–100.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Anuradha Bishnoi
    • 1
  • Davinder Parsad
    • 1
  1. 1.Department of DermatologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations